Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
05/2010
05/18/2010US7718614 Combination therapy of peptide vaccination and estramustine treatment
05/18/2010US7718608 Methods of treating a subject suffering from irritable bowel syndrome
05/18/2010US7718606 Methods for treating muscle diseases and disorders
05/18/2010US7718401 Expression of HIV polypeptides and production of virus-like particles
05/18/2010US7718387 Measuring circulating therapeutic antibody, antigen and antigen/antibody complexes using ELISA assays
05/18/2010US7718386 Methods for the diagnosis of diabetes
05/18/2010US7718382 Method for identifying compounds for treatment of pain
05/18/2010US7718359 Method of immunization against the 4 serotypes of dengue fever
05/18/2010US7718358 Method of immunization against the 4 dengue serotypes
05/18/2010US7718357 Method of immunization against the 4 dengue serotypes
05/18/2010US7718183 Proteins with repetitive bacterial-Ig-like (big) domains present in Leptospira species
05/18/2010US7718182 Using alkyl hydroperoxide reductase as tool in developing vaccines to prevent and treat microorganismal infection; immunotherapy
05/18/2010US7718180 Immunizing compositions comprising nucleic acids encoding the HIV-1 matrix protein myristate binding site
05/18/2010US7718179 Ostertagia vaccine
05/18/2010US7718178 Allergen formulation
05/18/2010US7718177 Antibodies directed to fragments of connective tissue growth factor (CTGF) polypeptide and methods and uses thereof
05/18/2010US7718176 Human EPO mimetic hinge core mimetibodies, compositions, methods and uses
05/18/2010US7718175 antibody composition comprising a Fc region with complex N-glycoside-linked sugar chains bound to the Fc region through N-acetylglucosamines of the reducing terminal of the sugar chains
05/18/2010US7718174 Anti-HGF/SF humanized antibody
05/18/2010US7718173 Anti-pro6094 antibodies
05/18/2010US7718172 Preparing monoclonal antibody to interleukins polypeptide for treating and preventing inflammatory bowel, crohn's, arthritis and psoriasis disorders
05/18/2010US7718166 Immunotherapy for prostate cancer using recombinant bacille Calmette-Guerin expressing prostate specific antigens
05/18/2010US7718165 live Plasmodium organism that is genetically engineered to disrupt a liver-stage-specific gene function; used for inoculating a vertebrate host against malaria
05/18/2010CA2557882C Defective packaging non-oncoviral vectors based on mpmv and hiv
05/18/2010CA2368965C Recombinant il-18 antagonists useful in treatment of il-18 mediated disorders
05/18/2010CA2296409C Agents comprising midkine or its inhibitor as active ingredient
05/18/2010CA2259143C G-beta-gamma regulated phosphatidylinositol-3' kinase p101 regulatory subunit
05/18/2010CA1341605C Synthetic antigen for the detection of aids-related disease
05/14/2010WO2010054403A1 Methods and compositions for treating complement-associated disorders
05/14/2010WO2010054397A2 N-cadherin: target for cancer diagnosis and therapy
05/14/2010WO2010054265A2 Monoclonal antibodies to fibroblast growth factor receptor 2
05/14/2010WO2010054156A2 Vaccines targeting cellular death receptors
05/14/2010WO2010054127A1 Methods and agents for stabilizing non-pathological amyloidogenic polypeptides
05/14/2010WO2010053978A2 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
05/14/2010WO2010053883A1 Live, attentuated respiratory syncytial virus
05/14/2010WO2010053877A2 Mhc ii associated protein and uses thereof
05/14/2010WO2010053814A1 Anti-tgf-beta receptor ii antibodies
05/14/2010WO2010053716A1 Improved anti-cd19 antibodies
05/14/2010WO2010053610A2 Stable anthrax vaccine formulations
05/14/2010WO2010053596A1 Bispecific intracellular delivery vehicles
05/14/2010WO2010053559A1 Mesothelin antibody protein fusions and methods of use
05/14/2010WO2010053433A1 Increased expression of specific antigens
05/14/2010WO2010053316A2 New use of sixth immunoglobulin-like domain of vcam-1
05/14/2010WO2010052556A1 Treatment with anti-alpha2 integrin antibodies
05/14/2010WO2010052505A1 Binding members against il-1r1
05/14/2010WO2010051820A1 Multiplexed cytokine vaccination
05/14/2010WO2010051635A1 Methods of improving the therapeutic efficacy and utility of antibody fragments
05/14/2010WO2010033798A3 Live bacterial vaccines resistant to carbon dioxide (co2), acidic ph and/or osmolarity for viral infection prophylaxis or treatment
05/14/2010WO2010033274A9 Nanoemulsion adjuvants
05/14/2010WO2010032141A3 Non-typeable haemophilus influenzae vaccines and their uses
05/14/2010WO2010022740A3 Hiv-1 envelope polypeptides for hiv vaccine
05/14/2010WO2010017443A3 Anti-beta-2-microglobulin agents and the use thereof
05/14/2010WO2010011999A3 Methods and compositions for eliciting an amyloid-selective immune response
05/14/2010WO2010008528A3 Marek's disease virus vaccine compositions and methods of using thereof
05/14/2010WO2010005868A3 A vaccine for porcine post-weaning diarrhea caused by enterotoxigenic escherichia coli
05/14/2010WO2010003053A3 Hsv-2 peptides for stimulation of cytotoxic t lymphocytes
05/14/2010WO2009040134A8 Heparin-binding epidermal growth factor-like growth factor antigen binding proteins
05/14/2010WO2008133706A8 Fully human anti-vegf antibodies and methods of using
05/14/2010CA2778435A1 Vaccines targeting cellular death receptors
05/14/2010CA2743133A1 N-cadherin: target for cancer diagnosis and therapy
05/14/2010CA2742961A1 Anti-tgf-beta receptor ii antibodies
05/14/2010CA2742955A1 Bispecific intracellular delivery vehicles
05/14/2010CA2742899A1 Treatment with anti-alpha2 integrin antibodies
05/14/2010CA2742808A1 Mesothelin antibody protein fusions and methods of use
05/14/2010CA2742802A1 Methods and compositions for treating complement-associated disorders
05/14/2010CA2742777A1 Methods of improving the therapeutic efficacy and utility of antibody fragments
05/14/2010CA2742531A1 Modulation of toll-like receptor 5 expression by antisense oligonucleotides
05/14/2010CA2742357A1 Binding members against il-1r1
05/14/2010CA2742254A1 Improved anti-cd19 antibodies
05/14/2010CA2742086A1 Live, attenuated respiratory syncytial virus
05/14/2010CA2741961A1 Novel method
05/14/2010CA2733668A1 Monoclonal antibodies to fibroblast growth factor receptor 2
05/14/2010CA2689726A1 Antibodies against gpi.alpha.
05/13/2010US20100122358 H-Chain-only antibodies
05/13/2010US20100121253 Method and Apparatus of Low Strength Electric Field Network-Mediated Delivery of Drug, Gene, SI-RNA, SH-RNA Protein, Peptide, Antibody or Other Biomedical and Therapeutic Molecules and Reagents in Solid Organs
05/13/2010US20100121039 Methods and compositions for prolonging elimination half-times of bioactive compounds
05/13/2010US20100121029 Anti-hiv immunogenic formulation and process for preparation thereof
05/13/2010US20100120688 ErbB Interface Peptidomimetics And Methods Of Use Thereof
05/13/2010US20100120056 Diagnosis and monitoring of diseases
05/13/2010US20100119610 Packaged pegylated gold nanoparticles
05/13/2010US20100119593 Liposome and method for producing the same
05/13/2010US20100119591 Use of lipid containing particles comprising quillaja saponins for the treatment of cancer
05/13/2010US20100119586 Patch for Cutaneous Application
05/13/2010US20100119570 Solid Pharmaceutical And Vaccine Dose
05/13/2010US20100119556 Methods and compositions for modulating an immune response with immunogenic oligonucleotides
05/13/2010US20100119555 Methods and Compositions for the Treatment and Diagnosis of Cancer
05/13/2010US20100119554 Transplants
05/13/2010US20100119553 Helicobacter pylori sialic acid binding adhesin, SabA and sabA - gene
05/13/2010US20100119552 Purification of vaccinia viruses using hydrophobic interaction chromatography
05/13/2010US20100119551 Methods and reagents for vaccination which generate a CD8 T cell immune response
05/13/2010US20100119550 Recombinant multivalent vaccine
05/13/2010US20100119549 Chlamydial antigens as reagents for diagnosis and treatment of chlamydial infection and disease
05/13/2010US20100119548 Injecting directly into a tumor; cancer vaccine
05/13/2010US20100119547 Recombinant Parainfluenza Virus Expression Systems And Vaccines
05/13/2010US20100119546 Vaccine against african horse sickness virus
05/13/2010US20100119545 Modified vaccinia ankara virus variant
05/13/2010US20100119544 Vaccine
05/13/2010US20100119543 Use of shigella invaplex to transport functional proteins and transcriptionally active nucleic acids across mammalian cell membranes in vitro and in vivo
05/13/2010US20100119540 Vaccination Regimen for B-Cell Vaccines
05/13/2010US20100119539 Vaccine against malaria, based on the 200l subuniti of plasmodium vivax msp1 protein
1 ... 532 533 534 535 536 537 538 539 540 541 542 543 544 545 546 547 548 549 550 551 552 ... 1823